Peer Review History
| Original SubmissionApril 15, 2021 |
|---|
|
PONE-D-21-12042 There’s no smoke without fire: smoking in smoke-free acute mental health wards PLOS ONE Dear Dr. Jenkin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Michael Cummings, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.When reporting the results of qualitative research, we suggest consulting the COREQ guidelines: http://intqhc.oxfordjournals.org/content/19/6/349. In this case, please consider please provide the interview guide used and please provide additional information regarding the interview guide development process, including the theories or frameworks which were employed. Furthermore, please reported the date ranges over which participants were recruited form the study and please include in your Methods section (or in Supplementary Information files) the participating hospitals/institutions 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Additional Editor Comments : Please do your best to address reviewer comments. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Study Summary - The authors conducted 85 semi-structured interviews with staff members and service users of four mental health facilities in New Zealand. The interviewers asked about the perceived effectiveness of smoke-free policies in the facilities and the perceived cause of lack of effectiveness. The authors used a social constructionist problem representation approach which "investigates how, and for whom, phenomena are represented as problems, and their implicit or explicit solutions." Study Results - Results of the interviews indicated that the majority of staff disregarded the facility's smoke-free policies laying out a series of concerns; denying cigarettes leads to patient distress and an increase in aggression and sometimes violence, enforcement problems, and smoking serves as a behavioral management tool. Most patients believed that smoking was important to socializing, reduced boredom, and helped them remain calm. A minority of staff and patients viewed smoking as a problem due to the fire hazard and made common areas less desirable. No one mentioned the health risks associated with smoking. Proposed solutions included increased consistency in enforcement, providing NRT and perhaps vaping, and making the therapeutic milieu more, well, therapeutic. Strengths - The study focuses on a central disparity issue in tobacco control as individuals with mental illness smoke cigarettes at much higher rates than the general population. They also tend to smoke more cigarettes per day, be more highly addicted, and suffer the chronic disease that inevitably follows. That said, it is unclear what this study actually adds to the discussion given the limitations below. Weaknesses/Limitations - The authors purposely took an approach in which context is eliminated from the discussion or just ignored. But that is a major flaw of this work and reduces any utility to the fields of tobacco control or mental health treatment. The focus is entirely on the current staff and patients and their perceptions about the law and the source of the "problem." Focusing on staff where the majority are generally non-compliant with the law will give a particular view that the law/policy is the primary problem. A minority of staff see smoking as the problem. I'm not sure what we learn from this that can move the discussion forward. It is exactly the context that was left out of the discussion that might be edifying for those trying to improve compliance with a law that could protect patients who are likely to suffer the negative consequences of smoking and secondhand smoke exposure. Some of the key contextual elements that we need to know more about include: How was the policy originally implemented and rolled out? Was there discussion with staff in advance of the new policy? Was there an educational component prior that explained the need for the policy (doubtful since no one mentioned associated health risks as a reason for having the policy)? Was there discussion about staff smoking and offers of free tobacco dependence treatment for staff prior to the law? Was there a reasonable time period from when the policy was announced until the time it became effective? These actions are policy 'best practices" and whether any occurred or not is entirely ignored in this paper. Many of the answers to these questions could explain much of the problems with compliance as well as the perceptions of the staff. How is tobacco dependence treatment (TDT) for patients managed on these mental health units? Is nicotine dependence treated as less important than the mental health diagnosis or as a secondary substance abuse diagnosis requiring treatment? From the description, treatment of tobacco dependence sounds limited to NRT. What about use of other medications like varenicline, now shown to be safe and effective for individuals with severe mental illness in the EAGLES study. Or the combination of long-acting and short-acting NRT and using higher doses of NRT. Effective use of current TDT does not seem well understood by the staff and it is unclear if the authors understand it either. Tellingly, the authors do consider the use of e-cigarettes though they note the varying concerns on their utility. Many of the statements from the staff suggest an anachronistic view of tobacco use by patients with mental illness. Suggesting that smoking on a mental health ward can serve as a relaxant, or that it reduces violence (in spite of the authors noting little support for that), or stating that smoking "is the only thing they have," are hopefully falling out of mainstream thinking in treating individuals with severe mental illness. Using smoking as a behavioral management tool (as positive reinforcement for example) is particularly onerous given the long term outcomes of smoking. That staff may join them outside to smoke makes the view more understandable but no more acceptable. So while the 'data' are interesting, without context in a number of key areas, there is little to guide the improvement of conditions in these wards. Reviewer #2: Dear Collegues I very much enjoyed reading your paper - ‘There’s no smoke without fire: smoking in smoke-free acute mental health wards’, of a qualitative study using interviews with 85 patients and staff in 4 wards in NZ and analysed using a social constructionist problem representation approach. The study extends the literature of smoking among people with mental health problems among in settings in NZ and contributes to the international literature. A few points you may want to consider 1. The Introduction is comprehensive and provides a useful background to the issue. Re the sentence ‘Quitting smoking at age 40 potentially gains six years of life expectancy for those with mental illness; [5, 6, 8-11]’, whist all these references refer to life expectancy gap between those with and without mental illness, with two of them providing primary data, I’m not sure if all of them either investigated or cited secondary references that quitting at 40 potentially gains six years of life expectancy for those with mental illness. Is it possible to have a check of these refs please? In addition to El-Guebaly (ref 29) and Lawn’s (refs 26, 30) work, more recent research about staff belief that smokefree polices are related to an increase in violence about violence is not supported by research findings. Eg Spaducci, G., Stubbs, B., McNeill, A., Stewart, D. and Robson, D. (2018), Violence in mental health settings: A systematic review. Int J Mental Health Nurs, 27: 33-45. https://doi.org/10.1111/inm.12425 Robson et al, Effect of implementation of a smoke-free policy on physical violence in a psychiatric inpatient setting: an interrupted time series analysisLancet Psychiatry 2017; 4: 540–46. http://dx.doi.org/10.1016/S2215-0366(17)30209-2 Methods Table 2 is very helpful to get an idea of the wards you recruited from. A little more info about what constitutes a ‘site’– for those readers not familiar with how NZ health services are organised, eg were the 4 District Health Boards spread throughout NZ? Were each of the 4 wards part of a mental health hospital or general hospital? Were they acute wards or long stay? Other than gender, the profile of patients (or staff is not clear), therefore readers won’t be able to judge if the background of the patients you interviewed are similar or different to those they work with; eg did the majority have a severe mental illness eg schizophrenia, bipolar disorder or more a common mental disorder eg – depression , anxiety; were they old or young, had they been in hospital for a long time or a short time? All these variables are likely to influence ones experience of a hospital policy. Similarly – were the staff young or old? How long had they worked in mental health? You recruited diverse group, though don’t give a breakdown of numbers from each professional role. Had any of the staff received train in smoking cessation? What was the smoking status of staff and pts? If none of the info was collected some acknowledgement should be mentioned in the limitations. Some context about what the policy involves – eg were these hospital policies just related to the environment (which you explain nicely in table 2) or did they also include a tobacco dependence treatment pathway/protocol and if so what did this involve? eg are smokers given NRT on arrival to the ward and thoughout their stay, is it prescribed regularly of do pts have to request it. Is behavioural support provided at all either by ward staff or trained tobacco dependance treatment advisors? The discussion is comprehensive. Some mention of staff education and training is pertinent when you discuss solutions. A couple of copy edit points ‘this MS report’s ‘Alternatively, smoking’s assumed calming effects may simply be the alleviation of withdrawal effects.[put ref above that I deleted here]’ Well done on a great study. Reviewer #3: This is an interesting article describing tobacco smoking in smoke-free mental health units in New Zealand. The authors apply a social constructionist problem representation approach to interpretation of semi-structured interview data. The framework guiding the analysis is infrequently used in the context of smokefree mental health research, and that is a strength of this paper. The manuscript however, is rather wordy and lacking in some pertinent details, and I feel that this detracts somewhat from its strengths. Some points that the authors might consider: Abstract: The stated aim of the study is to explore the smoking milieu in the mental health environment. However, the results imply the exploration of other factors in addition to the environment. It is also quite difficult to extract the conclusion from the abstract. It would help if the authors could make clear what they mean by ‘milieu’ – at present it is a little ambiguous. Introduction: Some of the cited material the authors rely on was published over a decade ago, the inclusion of references to more recent published articles on the implementation and evaluation of smokefree policies would be welcome here. It would also help to orientate international readers if a short summary of the New Zealand mental health landscape was provided. Furthermore, it would be helpful to know if service users are provided with any pharmacological or behavioural support as part of the smokefree policy. A little more detail on the research settings and locality of the findings described would also help the reader to determine contextual similarities and differences to the New Zealand context. This could also be revisited in the discussion. A large number of studies are referenced, but rather than provide a summary of the landscape the introduction would be more compelling if the evidence were used to compile a path forward and a rationale for the present study. Methods: The authors provide a rather brief overview of the methods they adopted, and leaves the reader with a number of questions. For example, a purposive approach to sampling of the staff group was used, was the same applied to service users? It appears that analysis comprised an iterative thematic approach. What is unclear is the actual process that was undertaken to derive the themes and subthemes. Was analysis undertaken by site/case? How were discrepancies in coding or theme generation resolved? Was a process of double coding employed? The authors should provide a full account of methods. A copy of the interview schedule as supplementary material would also be appreciated. Results: A table summarising participant characteristic and the inclusion of staff group or service user ward type (locked/unlocked) would help to locate the quotations in terms of perspective. It would also help if the frequencies and/or percentages were reported when discussing majority/minority etc. of participants. Discussion: The discussion provides details of the New Zealand experience of implementing smokefree policies in acute mental health settings. Whilst the authors experience is in part very similar to that reported by other researchers in other developed countries, there are some local differences and I encourage the authors to expand on the differences; such as the predominance of locked settings and the issue of second-hand smoke in outdoor court yards. It is also helpful that the authors consider the implications of their findings and make recommendations. The limitations might also make mention as to the generalisability of findings within New Zealand and more widely. Perhaps also the authors might consider the impact that those service users who were not or could not be recruited to the study may have on the findings. The inclusion of e-cigarettes in the discussion is very interesting and relevant. I would encourage the authors to expand on this, particularly in relation to its implementation in the New Zealand context. I would also encourage the authors to identity additional literature from all perspectives in relation to e-cigarettes. Conclusion: The conclusion seems to lose its way a little. Mention of the more notable findings with potential further avenues for research would I’m sure be appreciated by readers. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
There’s no smoke without fire: smoking in smoke-free acute mental health wards PONE-D-21-12042R1 Dear Dr. Jenkin, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michael Cummings, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: N/A Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Dear Authors I enjoyed reading your revised manuscript. Thanks for addressesing my commennts in the initial review Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-21-12042R1 There’s no smoke without fire: smoking in smoke-free acute mental health wards Dear Dr. Jenkin: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michael Cummings Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .